We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+27.44%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$6.27B
AUM Growth
+$1.32B
Cap. Flow
+$81.3M
Cap. Flow %
1.3%
Top 10 Hldgs %
29.27%
Holding
150
New
7
Increased
71
Reduced
48
Closed
5

Top Sells

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$42.1M
2
PRLB icon
Protolabs
PRLB
+$36.3M
3
RGEN icon
Repligen
RGEN
+$26.1M
4
WDFC icon
WD-40
WDFC
+$11.2M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$8.43M

Sector Composition

Rank Sector Weight
1 Technology 33.67%
2 Industrials 28.38%
3 Healthcare 17.2%
4 Consumer Discretionary 8.25%
5 Materials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WST icon
51
West Pharmaceutical
WST
$24.9B
$27M 0.43%
95,262
+5,035
+6% +$1.41M
BFAM icon
52
Bright Horizons
BFAM
$3.86B
$24.6M 0.39%
141,977
+7,655
+6% +$1.25M
HEI.A icon
53
HEICO Corp Class A
HEI.A
$37.2B
$23.4M 0.37%
199,543
+10,649
+6% +$1.16M
TYL icon
54
Tyler Technologies
TYL
$12.8B
$21.8M 0.35%
49,924
+2,450
+5% +$1.01M
JKHY icon
55
Jack Henry & Associates
JKHY
$11.1B
$21.2M 0.34%
130,660
+32,685
+33% +$5.19M
GWRE icon
56
Guidewire Software
GWRE
$14.2B
$20.7M 0.33%
160,655
+7,825
+5% +$893K
FICO icon
57
Fair Isaac
FICO
$22.5B
$20.3M 0.32%
39,667
+2,130
+6% +$991K
GGG icon
58
Graco
GGG
$13.5B
$19.8M 0.32%
273,714
+14,455
+6% +$967K
MTN icon
59
Vail Resorts
MTN
$5.3B
$19.8M 0.32%
70,924
+3,935
+6% +$1.02M
IAA
60
DELISTED
IAA, Inc. Common Stock
IAA
$19.4M 0.31%
298,619
+16,155
+6% +$967K
TFX icon
61
Teleflex
TFX
$5.98B
$18.5M 0.3%
44,997
+2,635
+6% +$972K
CGNX icon
62
Cognex
CGNX
$11.3B
$17.6M 0.28%
219,560
+15,280
+7% +$1.11M
SLP icon
63
Simulations Plus
SLP
$371M
$17.1M 0.27%
237,611
+213,106
+870% +$14.1M
WSO icon
64
Watsco Inc
WSO
$13.6B
$15M 0.24%
66,046
+3,515
+6% +$808K
ATR icon
65
AptarGroup
ATR
$8.61B
$14.7M 0.23%
107,177
+27,320
+34% +$3.39M
HCAT icon
66
Health Catalyst
HCAT
$128M
$12.7M 0.2%
291,404
+13,760
+5% +$508K
GNRC icon
67
Generac Holdings
GNRC
$12.5B
$12.6M 0.2%
55,344
+2,895
+6% +$623K
ANSS
68
DELISTED
Ansys
ANSS
$12.2M 0.19%
33,621
-14,375
-30% -$4.81M
LCII icon
69
LCI Industries
LCII
$2.65B
$11.3M 0.18%
87,479
+4,505
+5% +$554K
CPRT icon
70
Copart
CPRT
$27.5B
$10.9M 0.17%
341,736
+12,620
+4% +$368K
IT icon
71
Gartner
IT
$11.7B
$10.2M 0.16%
63,602
+3,500
+6% +$504K
AVLR
72
DELISTED
Avalara, Inc.
AVLR
$7.08M 0.11%
+42,950
New +$6.87M
VCEL icon
73
Vericel Corp
VCEL
$2.31B
$2.46M 0.04%
79,750
-26,750
-25% -$637K
CDXS icon
74
Codexis
CDXS
$158M
$2.21M 0.04%
101,085
-13,625
-12% -$224K
CDNA icon
75
CareDx
CDNA
$2.42B
$1.97M 0.03%
27,225
-20,930
-43% -$1.21M

Similar funds

Conestoga Capital Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Conestoga Capital Advisors held 150 positions worth $6.27B, up 27% from $4.96B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Conestoga Capital Advisors's Q4 2020 filing shows 7 new, 71 increased, 48 reduced and 5 closed positions. Its largest new stake was Vertex: 2,572,160 shares worth $89.6M. The largest sale was Bio-Techne, an estimated $42.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

  • Conestoga Capital Advisors's largest Q4 2020 buy was Vertex: 2,572,160 shares worth $89.6M.
  • Conestoga Capital Advisors added most to MODEL N, INC. in Q4 2020, an estimated $45.2M increase.
  • Conestoga Capital Advisors's biggest Q4 2020 reduction was Bio-Techne, cutting an estimated $42.1M.
  • Conestoga Capital Advisors fully exited Protolabs in Q4 2020, selling an estimated $36.3M.
  • Conestoga Capital Advisors's ten largest holdings make up 29% of its $6.27B portfolio in Q4 2020.
  • Conestoga Capital Advisors opened 7 new positions and closed 5 in Q4 2020.
  • Conestoga Capital Advisors's portfolio value rose 27% quarter-over-quarter to $6.27B.

Based on Conestoga Capital Advisors's 13F filing for Q4 2020, filed 26 Jan 2021.